Zachary K. Goldsmith, et al. “Sirtuin Inhibitor As a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal Melanoma”. The Ophthalmology, Sept. 2019, pp. 21-31, https://openventio.us/index.php/TOOJ/article/view/1235.